Ardelyx, Inc. (ARDX)
NASDAQ: ARDX · IEX Real-Time Price · USD
6.42
+0.11 (1.74%)
At close: Apr 26, 2024, 4:00 PM
6.45
+0.03 (0.47%)
After-hours: Apr 26, 2024, 7:57 PM EDT

Ardelyx Revenue

In the year 2023, Ardelyx had annual revenue of $124.46M with 138.61% growth. Revenue in the quarter ending December 31, 2023 was $34.36M, a -22.22% decrease year-over-year.

Revenue (ttm)
$124.46M
Revenue Growth
+138.61%
P/S Ratio
12.00
Revenue / Employee
$466,127
Employees
267
Market Cap
1.49B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023124.46M72.30M138.61%
Dec 31, 202252.16M42.06M416.57%
Dec 31, 202110.10M2.53M33.36%
Dec 31, 20207.57M2.29M43.36%
Dec 31, 20195.28M2.67M102.57%
Dec 31, 20182.61M-39.39M-93.79%
Dec 31, 201742.00M--
Dec 31, 20160--
Dec 31, 201524.03M-7.60M-24.02%
Dec 31, 201431.62M2.70M9.32%
Dec 31, 201328.93M23.52M434.71%
Dec 31, 20125.41M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Warby Parker 669.77M
U.S. Physical Therapy 604.80M
ADMA Biologics 258.22M
Dynavax Technologies 232.28M
LeMaitre Vascular 193.48M
Gyre Therapeutics 113.45M
Protagonist Therapeutics 60.00M
Revenue Rankings